Compare Boston Scientific Corporation (BSX) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Ginkgo Bioworks Holdings Inc — how do they compare? Boston Scientific Corporation trades at $50.96 (market cap $74.19B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Boston Scientific Corporation is far larger — about 146.7× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.
| BSX | DNA | |
|---|---|---|
Market Cap | $74.19B | $505.73M |
Sector | Health | Health |
52-Week High | $108.14 | $16.14 |
52-Week Low | $42.63 | $5.48 |
Enterprise Value | $86.27B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
